BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines

Cancer Cell - United States
doi 10.1016/j.ccell.2018.11.004
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

The BH3 Mimetic Drug ABT-737 Induces Apoptosis and Acts Synergistically With Chemotherapeutic Drugs in Thyroid Carcinoma Cells

Cancer Cell International
Cancer ResearchOncologyGenetics
2016English

DRP-1 Is Required for BH3 Mimetic-Mediated Mitochondrial Fragmentation and Apoptosis

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2017English

Hope for Insulin Mimetic Oral Antidiabetic Drugs

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
1999English

Blazing a Trail: The African Protocol on Women's Rights Comes Into Force

Journal of African Law
Law
2006English

The BH3 Mimetic ABT-737 Increases Treatment Efficiency of Paclitaxel Against Hepatoblastoma

BMC Cancer
Cancer ResearchOncologyGenetics
2011English

Epothilones - New Anti-Cancer Medicines

Kontakt
EnvironmentalPublic HealthPhilosophyNursingOccupational Health
2007English

New Drugs for Medullary Thyroid Cancer: New Promises?

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2016English

Synergistic Induction of Cell Death in Liver Tumor Cells by TRAIL and Chemotherapeutic Drugs via the BH3-only Proteins Bim and Bid

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2010English

Financial Incompatibility and Paired Kidney Exchange: Walking a Tightrope or Blazing a Trail?

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy